[1]
Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation. 1999 Jun 8:99(22):2901-7
[PubMed PMID: 10359734]
Level 1 (high-level) evidence
[2]
Ripatti P, Rämö JT, Mars NJ, Fu Y, Lin J, Söderlund S, Benner C, Surakka I, Kiiskinen T, Havulinna AS, Palta P, Freimer NB, Widén E, Salomaa V, Tukiainen T, Pirinen M, Palotie A, Taskinen MR, Ripatti S, FinnGen†. Polygenic Hyperlipidemias and Coronary Artery Disease Risk. Circulation. Genomic and precision medicine. 2020 Apr:13(2):e002725. doi: 10.1161/CIRCGEN.119.002725. Epub 2020 Mar 10
[PubMed PMID: 32154731]
[3]
Quispe R, Hendrani AD, Baradaran-Noveiry B, Martin SS, Brown E, Kulkarni KR, Banach M, Toth PP, Brinton EA, Jones SR, Joshi PH. Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7. Archives of medical science : AMS. 2019 Sep:15(5):1195-1202. doi: 10.5114/aoms.2019.87207. Epub 2019 Aug 22
[PubMed PMID: 31572464]
[4]
Hegele RA,Ban MR,Hsueh N,Kennedy BA,Cao H,Zou GY,Anand S,Yusuf S,Huff MW,Wang J, A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia. Human molecular genetics. 2009 Nov 1;
[PubMed PMID: 19656773]
[5]
Föger B, Ritsch A, Doblinger A, Wessels H, Patsch JR. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia. Arteriosclerosis, thrombosis, and vascular biology. 1996 Dec:16(12):1430-6
[PubMed PMID: 8977446]
[6]
Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. Journal of lipid research. 1996 Apr:37(4):693-707
[PubMed PMID: 8732771]
[7]
Johansen CT, Wang J, Lanktree MB, McIntyre AD, Ban MR, Martins RA, Kennedy BA, Hassell RG, Visser ME, Schwartz SM, Voight BF, Elosua R, Salomaa V, O'Donnell CJ, Dallinga-Thie GM, Anand SS, Yusuf S, Huff MW, Kathiresan S, Cao H, Hegele RA. An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia. Arteriosclerosis, thrombosis, and vascular biology. 2011 Aug:31(8):1916-26. doi: 10.1161/ATVBAHA.111.226365. Epub 2011 May 19
[PubMed PMID: 21597005]
[8]
Laskarzewski PM,Khoury P,Kelly K,Mellies MJ,Morrison JA,Glueck CJ, Prevalence of familial hypertriglyceridemia: the Princeton School District Family Study. Preventive medicine. 1982 May;
[PubMed PMID: 7111228]
[9]
Toyama MT, Lewis MP, Kusske AM, Reber PU, Ashley SW, Reber HA. Ischaemia-reperfusion mechanisms in acute pancreatitis. Scandinavian journal of gastroenterology. Supplement. 1996:219():20-3
[PubMed PMID: 8865466]
[10]
Navina S, Acharya C, DeLany JP, Orlichenko LS, Baty CJ, Shiva SS, Durgampudi C, Karlsson JM, Lee K, Bae KT, Furlan A, Behari J, Liu S, McHale T, Nichols L, Papachristou GI, Yadav D, Singh VP. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Science translational medicine. 2011 Nov 2:3(107):107ra110. doi: 10.1126/scitranslmed.3002573. Epub
[PubMed PMID: 22049070]
[11]
Nayak KR, Daly RG. Images in clinical medicine. Eruptive xanthomas associated with hypertriglyceridemia and new-onset diabetes mellitus. The New England journal of medicine. 2004 Mar 18:350(12):1235
[PubMed PMID: 15028827]
[12]
Berglund L,Brunzell JD,Goldberg AC,Goldberg IJ,Sacks F,Murad MH,Stalenhoef AF, Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 2012 Sep;
[PubMed PMID: 22962670]
Level 1 (high-level) evidence
[14]
Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet (London, England). 2010 May 8:375(9726):1634-9. doi: 10.1016/S0140-6736(10)60545-4. Epub
[PubMed PMID: 20452521]
[15]
Aljenedil S, Hegele RA, Genest J, Awan Z. Estrogen-associated severe hypertriglyceridemia with pancreatitis. Journal of clinical lipidology. 2017 Jan-Feb:11(1):297-300. doi: 10.1016/j.jacl.2016.12.006. Epub 2016 Dec 23
[PubMed PMID: 28391900]
[16]
Kim Y,Miller M, Marked hypertriglyceridemia in a woman receiving metoprolol succinate. Journal of clinical lipidology. 2014 Nov-Dec
[PubMed PMID: 25499948]
[17]
Feeney ER, Mallon PW. HIV and HAART-Associated Dyslipidemia. The open cardiovascular medicine journal. 2011:5():49-63. doi: 10.2174/1874192401105010049. Epub 2011 Feb 24
[PubMed PMID: 21643501]
[18]
Brunzell JD. Clinical practice. Hypertriglyceridemia. The New England journal of medicine. 2007 Sep 6:357(10):1009-17
[PubMed PMID: 17804845]
[19]
Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, Didangelos TP, Carina MV, Kranitsas DF, Kontopoulos AG. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia. The American journal of cardiology. 1997 Sep 1:80(5):608-13
[PubMed PMID: 9294990]
[20]
Pradhan A,Bhandari M,Vishwakarma P,Sethi R, Triglycerides and Cardiovascular Outcomes-Can We REDUCE-IT ? The International journal of angiology : official publication of the International College of Angiology, Inc. 2020 Mar
[PubMed PMID: 32132810]
[21]
Johansen CT, Hegele RA. The complex genetic basis of plasma triglycerides. Current atherosclerosis reports. 2012 Jun:14(3):227-34. doi: 10.1007/s11883-012-0243-2. Epub
[PubMed PMID: 22528520]
[22]
Corredor-Andrés B, Muñoz-Calvo MT, Calero O, Aparicio C, Argente J, Calero M. Nephrotic syndrome associated with severe hypertriglyceridemia in a pediatric patient: Answers. Pediatric nephrology (Berlin, Germany). 2018 Nov:33(11):2075-2078. doi: 10.1007/s00467-018-3919-1. Epub 2018 Mar 12
[PubMed PMID: 29532233]
[23]
O'Brien T, Dinneen SF, O'Brien PC, Palumbo PJ. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clinic proceedings. 1993 Sep:68(9):860-6
[PubMed PMID: 8371604]
[24]
Ståhlberg D,Reihnér E,Rudling M,Berglund L,Einarsson K,Angelin B, Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase. Hepatology (Baltimore, Md.). 1995 Apr;
[PubMed PMID: 7705775]
[25]
Cefali EA, Simmons PD, Stanek EJ, Shamp TR. Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation. International journal of clinical pharmacology and therapeutics. 2006 Dec:44(12):633-40
[PubMed PMID: 17190373]
[26]
Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP, Diabetes Multicenter Research Group. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. Archives of internal medicine. 2002 Jul 22:162(14):1568-76
[PubMed PMID: 12123399]
[27]
Mikhail N, Trivedi K, Page C, Wali S, Cope D. Treatment of severe hypertriglyceridemia in nondiabetic patients with insulin. The American journal of emergency medicine. 2005 May:23(3):415-7
[PubMed PMID: 15915436]
[28]
Ipe TS,Pham HP,Williams LA 3rd, Critical updates in the 7{sup}th{/sup} edition of the American Society for Apheresis guidelines. Journal of clinical apheresis. 2018 Feb;
[PubMed PMID: 28653762]
[29]
Fei F, Boshell N, Williams LA 3rd. Predictability and efficacy of therapeutic plasma exchange for hypertriglyceridemia induced acute pancreatitis. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2020 Apr:59(2):102699. doi: 10.1016/j.transci.2019.102699. Epub 2019 Dec 24
[PubMed PMID: 32085931]